Table 3.
Predictive Value of CSF α-Syn in Cognitive Decline
Test | Baseline: phase 1 |
Final: phase 2 |
||||
---|---|---|---|---|---|---|
Coefficient | SE | P value | Coefficient | SE | P value | |
SDMT | −0.0445 | 0.0737 | 0.546 | −0.1071 | 0.0707 | 0.131 |
SRT-Total Recall∗ | −0.1301 | 0.0950 | 0.183 | −0.1240 | 0.0590 | 0.037 |
SRT-Delayed Recall | −0.0151 | 0.0276 | 0.587 | −0.0516 | 0.0166 | 0.002 |
New Dot Test | −0.0062 | 0.0154 | 0.686 | −0.0326 | 0.0103 | 0.002 |
See Table 2 for the phase 2 results, with or without controlling for mean LEDD.
Bold indicates significance at the P < 0.05 level.
Controlling for age, sex, education, baseline UPDRS, baseline test score, length of exposure to deprenyl, and exposure to tocopherol.